Aging-associated increase in indoleamine 2,3-dioxygenase (IDO) activity appears to be unrelated to the transcription of the IDO1 or IDO2 genes in peripheral blood mononuclear cells

Immunity and Ageing

Volumn 8, Issue , 2011, Pages

  Marttila, Saara ^a   Jylhävä, Juulia ^a   Eklund, Carita ^a   Hervonen, Antti ^a   Jylhä, Marja ^a   Hurme, Mikko ^a,b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

INDOLEAMINE 2,3 DIOXYGENASE;

ADULT; ARTICLE; COMPARATIVE STUDY; ENZYME ACTIVITY; FEMALE; GENE; GENE ACTIVITY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; INDOLEAMINE 2,3 DIOXYGENASE 1 GENE; INDOLEAMINE 2,3 DIOXYGENASE 2 GENE; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL;

EID: 80053653274     PISSN: None     EISSN: 17424933     Source Type: Journal    
DOI: 10.1186/1742-4933-8-9     Document Type: Article

References (20)

1. De Martinis M, Franceschi C, Monti D, Ginaldi L. Inflamm-ageing and lifelong antigenic load as major determinants of ageing rate and longevity. FEBS Lett 2005, 579:2035-2039. 10.1016/j.febslet.2005.02.055, 15811314.
2. Bruunsgaard H, Pedersen M, Pedersen BK. Aging and proinflammatory cytokines. Curr Opin Hematol 2001, 8:131-136. 10.1097/00062752-200105000-00001, 11303144.
3. Schröcksnadel K, Wirleitner B, Winkler C, Fuchs D. Monitoring tryptophan metabolism in chronic immune activation. Clin Chim Acta 2006, 364:82-90. 10.1016/j.cca.2005.06.013, 16139256.
4. Soliman H, Mediavilla-Varela M, Antonia S. Indoleamine 2,3 dioxygenase: Is it an immune suppressor?. Cancer J 2010, 16:354-359. 10.1097/PPO.0b013e3181eb3343, 20693847.
5. Xu H, Zhang G-X, Ciric B, Rostami A. IDO: A double-edged sword for Th1/Th2 regulation. Immunol Lett 2008, 121:1-6. 10.1016/j.imlet.2008.08.008, 2628165, 18824197.
6. King NJC, Thomas SR. Molecules in focus: Indoleamine 2,3-dioxygenase. Int J Biochem Cell Biol 2007, 39:2167-2172. 10.1016/j.biocel.2007.01.004, 17320464.
7. Metz R, DuHadaway JB, Kamasani U, Laury-Kleintop L, Muller AJ, Predegast GC. Novel tryptophan catabolic enzyme IDO2 is preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase compound D-1-methyl-tryptophan. Cancer Res 2007, 67:7082-7087. 10.1158/0008-5472.CAN-07-1872, 17671174.
8. Ball HJ, Yuasa HJ, Austin CJD, Weiser S, Hunt NH. Indoleamine 2,3-dioxygenase-2: a new enzyme in the kynurenine pathway. Int J Biochem Cell Biol 2009, 41:467-471. 10.1016/j.biocel.2008.01.005, 18282734.
9. Ball HJ, Sanches-Perez A, Weiser S, Austin CJD, Astelbauer F, Miu J, McQuillan JA, Stocker R, Jermin LS, Hunt NH. Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice. Gene 2007, 396:203-213. 10.1016/j.gene.2007.04.010, 17499941.
10. Frick B, Schröcksnadel K, Neurauter G, Leblhuber F, Fuchs D. Increasing production of homocysteine and neopterin and degradation of tryptophan with older age. Clin Biochem 2004, 37:684-687. 10.1016/j.clinbiochem.2004.02.007, 15302611.
11. Fuchs D, Forsman A, Hagberg L, Larsson M, Norkrans G, Reibnegger G, Werner ER, Wachter H. Immune activation and decreased tryptophan in patients with HIV-1 infection. J Interferon Res 1990, 10:599-603. 10.1089/jir.1990.10.599, 2128302.
12. Huengsberg M, Winer JB, Gompels M, Round R, Ross J, Shahmanesh M. Serum kynurenine-to-tryptophan ratio increases with progressive disease in HIV-infected patients. Clin Chem 1998, 44:858-62.
13. Boasso A, Herbeuval J-P, Hardy AW, Anderson SA, Dolan MJ, Fuchs D, Shearer GM. HIV inhibits CD4+ T cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells. Blood 2007, 109:3351-3359. 10.1182/blood-2006-07-034785, 1852248, 17158233.
14. Pertovaara M, Raitala A, Lehtimäki T, Karhunen PJ, Oja SS, Jylhä M, Hervonen A, Hurme M. Indoleamine 2,3-dioxygenase activity in nonagenarians is markedly increased and predicts mortality. Mech Ageing Dev 2006, 127:497-499. 10.1016/j.mad.2006.01.020, 16513157.
15. Goebeler S, Jylhä M, Hervonen A. Medical history, cognitive status and mobility at the age of 90. A population-based study in Tampere, Finland. Aging Clin Exp Res 2003, 15:154-161.
16. Laich A, Neurauter G, Widner B, Fuchs D. More rapid method for simultaneous measurement of tryptophan and kynurenine by HPLC. Clinical Chemistry 2002, 48:579-581.
17. Däubener W, Schmidt SK, Heseler K, Spekker KH, MacKenzie CR. Antimicrobial and Immunoregulatory effector mechanisms in human endothelial cells. Indoleamine 2,3-dioxygenase vesus inducible nitric oxide synthase. Thromb Haemost 2009, 102:1110-1116.
18. Wang Y, Liu H, McKenzie G, Witting PK, Stasch J-P, Hahn M, Changsirivathanathamrong D, Wu BJ, Ball HJ, Thomas SR, Kapoor V, Celermajer DS, Mellor AL, Keaney JF, Hunt NH, Stocker R. Kynurenine is an endothelium-derived relaxing factor produced during inflammation. Nat Med 2010, 16:279-285. 10.1038/nm.2092, 20190767.
19. Beutelspacher SC, Tan PH, McClure MO, Larkin DFP, Lechler RI, George AJT. Expression of indoleamine 2,3-dioxygenase (IDO) by endothelial cells: Implications for the control of alloresponses. Am J Transplant 2006, 6:1320-1330. 10.1111/j.1600-6143.2006.01324.x, 16686756.
20. Johnson BA, Baban B, Mellor AL. Targetting the immunoregulatory indoleamine 2,3 dioxygenase pathway in immunotherapy. Immunotherapy 2009, 1:645-661. 2746500, 20161103.